Early versus late identification of infants at high risk of developing moderate to severe bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 21, Issue 6, 1996, Pages 345-352

  Rozycki, Henry J ^a   Narla, Lakshmana ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; receiver operator curves; risk assessment

Indexed keywords

LUNG SURFACTANT EXTRACT; STEROID;

ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; PATIENT CODING; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

BRONCHOPULMONARY DYSPLASIA; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; PULMONARY SURFACTANTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0029977514     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199606)21:6<345::AID-PPUL1>3.0.CO;2-K     Document Type: Review

References (22)

1. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: Selection criteria for clinical trials. Pediatrics. 1990; 86:728-736.
2. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994; 36:122-128.
3. Rozycki HJ, Byron PR, Gutcher G, McFadden M, Elliott GR, Kish CW. Beclomethasone for BPD: A model of aerosol therapy to intubated neonates. J Biopharm Sci. 1992; 3:177-183.
4. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics. 1992; 90:663-668.
5. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics. 1988; 82:527-532.
6. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989; 320:1505-1510.
7. Yen TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J Pediatr. 1990; 117:273-282.
8. Vijayakumar E, Soll RF, Bracken MB, Sinclair JC. Early postnatal corticosteroids for the prevention of chronic lung disease (CLD): Meta-analysis of clinical trials. Pediatr Res. 1995; 37:276A.
9. Edwards DK. Radiology of hyaline membrane disease, transient tachypnea of the newborn and bronchopulmonary dysplasia. In: Farrell PM, ed. Lung Development: Biological and Clinical Prespectives. New York. Academic Press, 1982:47-89.
10. Walsh MC, Kleigman RM. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am. 1986; 33: 179-201.
11. Rozycki HJ, Kirkpatrick BV. New developments in BPD. Pediatr Ann. 1993; 22:532-538.
12. Werner JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992; 120: 286-291.
13. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial. Pediatrics. 1991; 88:421-427.
14. Brozanksi BS, Jones JG, Gilmour CH, Balsan MJ, Vasquez RL, Israel BA, Newman B, Mimouni FB, Guthrie RD. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant. J Pediatr. 1995; 126:769-776.
15. Beck R, Anderson KD, Pearson GD, Cronin J, Miller MK, Short BL. Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn. J Pediatr Surg. 1986; 21:297-302.
16. Palta M, Gabbert D, Weinstein MR, Peters ME. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Pediatr. 1991; 119:285-292.
17. Cooke RWI. Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1991; 66:767-779.
18. Van Liedre S, Smith J, Devlieger H, Eggermont E. Outcome of respiratory distress syndrome at 28 days: A prospective longitudinal study. Eur Respir J. 1992; 5:1243-1248.
19. Van Lierde S, Smith J, Devlieger H, Eggermont E. Pulmonary mechanics during respiratory distress syndrome in the prediction of outcome and differentiation of mild and severe bronchopulmonary dysplasia. Pediatr Pulmonol. 1994; 17:218-224.
20. Bhutani VK, Abbasi S. Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life. J Pediatr. 1992; 120:605-613.
21. Corcoran JD, Patterson CC, Thomas PS, Halliday HL. Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: Results of a multivariate logistic regression analysis. Eur J Pediatr. 1993; 152:677-681.
22. Ryan SW, Wild NJ, Arthur RJ, Shaw BNJ. Prediction of chronic neonatal lung disease in very low birthweight neonates using clinical and radiological variables. Arch Dis Child. 1994; 71:F36-F39.